Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide. (Q40571240)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15057264%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15057264%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

Herpes simplex virus type 1

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15057264%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Roberto Manservigi

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15057264%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Rafaela Argnani

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15057264%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Luca Boccafogli

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15057264%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

1 July 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15057264%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15057264%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15057264%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15057264%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

1087-1098

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15057264%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302266

26 December 2019

exact match

0 references

cites work

Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

Gene therapy with viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

Latest development in viral vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

Virus-based gene delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

Viral vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

Friendly fire: redirecting herpes simplex virus-1 for therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

Pseudotyping of glycoprotein D-deficient herpes simplex virus type 1 with vesicular stomatitis virus glycoprotein G enables mutant virus attachment and entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

Targeting gene expression using HSV vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

Targeted gene delivery by tropism-modified adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

Ligand-directed retroviral targeting of human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

Tropism-modified adenoviral and adeno-associated viral vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

Inborn errors presenting with liver dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

Gene therapy progress and prospects: alpha-1 antitrypsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

Gene transfer into the liver by plasmid injection into the portal vein combined with electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

Liver as an ideal target for gene therapy: expression of CTLA4Ig by retroviral gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

Liver-directed gene transfer vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

Retroviral gene transfer to the liver in vivo during tri-iodothyronine induced hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

Hepatocyte-based gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

Liver repopulation with hepatocyte transplantation: new avenues for gene and cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

Neoadjuvant treatment of hepatic malignancy: an oncolytic herpes simplex virus expressing IL-12 effectively treats the parent tumor and protects against recurrence-after resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

Retrovirus-mediated in vivo gene transfer in the replicating liver using recombinant hepatocyte growth factor without liver injury or partial hepatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

Gene therapy as an alternative to liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

Efficient retroviral gene transfer to the liver in vivo using nonpolypeptidic mitogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

Herpes simplex virus type 1-based amplicon vector systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

Gene delivery and gene therapy with herpes simplex virus-based vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

Replication-defective genomic herpes simplex vectors: design and production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

The use of a genetically engineered herpes simplex virus (R7020) with ionizing radiation for experimental hepatoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

Replication-competent herpes simplex viral vectors for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

Prodrug bioactivation and oncolysis of diffuse liver metastases by a herpes simplex virus 1 mutant that expresses the CYP2B1 transgene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

Squalene: potential chemopreventive agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

Excretion of non-infectious virus particles lacking glycoprotein H by a temperature-sensitive mutant of herpes simplex virus type 1: evidence that gH is essential for virion infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

The putative cell receptors for hepatitis B virus (HBV), annexin V, and apolipoprotein H, bind to lipid components of HBV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

HepG2 cell binding activities of different hepatitis b virus isolates: inhibitory effect of anti-HBs and anti-preS1(21–47)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

PreS1-specific binding proteins as potential receptors for hepatitis B virus in human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

Mutational analysis of the major heparan sulfate-binding domain of herpes simplex virus type 1 glycoprotein C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

Engineered herpes simplex virus 1 is dependent on IL13Ralpha 2 receptor for cell entry and independent of glycoprotein D receptor interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

A solid-phase enzyme immunoassay for the determination of IgM and IgG antibodies against translation products of pre-S1 and pre-S2 regions of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

Recombinant herpes simplex virus type 1 engineered for targeted binding to erythropoietin receptor-bearing cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

1 reference

7 January 2021

Engineering Herpes Simplex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

7 January 2021

Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

7 January 2021

The first immunoglobulin-like domain of HveC is sufficient to bind herpes simplex virus gD with full affinity, while the third domain is involved in oligomerization of HveC.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

7 January 2021

Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

7 January 2021

Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

7 January 2021

Incorporation of CD4 into virions by a recombinant herpes simplex virus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302266

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302266

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15057264%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

26 December 2019

0 references

1 reference